![William Duke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Duke
Amministratore Delegato presso
INVIVYD, INC.
Patrimonio netto: 93 929 $ in data 30/06/2026
Profilo
William E.
Duke is Chief Executive, Financial & Accounting Officer at Invivyd, Inc. since 2024.
Former roles include Chief Financial Officer at Apexigen, Inc. from 2022 to 2023; Chief Financial & Accounting Officer at Kaleido Biosciences, Inc. from 2019 to 2022; Chief Financial Officer, Secretary & Treasurer at Pulmatrix, Inc. from 2015 to 2019; Chief Financial Officer & Head-Investor Relations at Valeritas, Inc. in 2015; Senior Director-Finance at Genzyme Corp.
from 2010 to 2011; Director-Finance & Accounting at Haemonetics Corp.
from 2008 to 2010; Chief Financial Officer at g8wave Holdings, Inc. from 2007 to 2008; and Chief Financial Officer at OTF Group, Inc. Education includes an MBA from Bentley University and undergraduate studies at Stonehill College, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
INVIVYD, INC. 0,05% | 20/03/2026 | 107.717 ( 0,05% ) | 93 929 $ | 30/06/2026 |
Posizioni attive di William Duke
| Società | Posizione | Inizio |
|---|---|---|
| INVIVYD, INC. | Amministratore Delegato | 30/05/2024 |
Precedenti posizioni note di William Duke
| Società | Posizione | Fine |
|---|---|---|
| APEXIGEN, INC. | Direttore Finanziario/CFO | 23/08/2023 |
| KALEIDO BIOSCIENCES, INC. | Direttore Finanziario/CFO | 08/04/2022 |
| PULMATRIX, INC. | Direttore Finanziario/CFO | 22/11/2019 |
| VALERITAS INC | Direttore Finanziario/CFO | 01/06/2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Direttore Finanziario/CFO | - |
Formazione di William Duke
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Haemonetics Corp.
 Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
g8wave Holdings, Inc.
 g8wave Holdings, Inc. Specialty TelecommunicationsCommunications Provides planning, creating and executing effective mobile marketing campaigns and content distribution strategies | Communications |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stonehill College, Inc.
 Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OTF Group, Inc.
 OTF Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
